FDA issues draft guidance for approving personalized gene-editing therapies for rare diseases
The FDA on Tuesday issued draft guidance laying out how sponsors can seek approval for gene-editing therapies tailored to each patient's genetic variant, the Department of Health and Human Services (HHS) said.